Please note that due to a high volume of submissions, the ANZCTR is currently experiencing a delay in processing of submissions.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/show/NCT00157144




Registration number
NCT00157144
Ethics application status
Date submitted
9/09/2005
Date registered
12/09/2005
Date last updated
10/03/2014

Titles & IDs
Public title
Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005
Scientific title
Secondary ID [1] 0 0
186/04
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Respiratory Distress Syndrome, Adult 0 0
Respiratory Insufficiency 0 0
Shock, Cardiogenic 0 0
Condition category
Condition code
Respiratory 0 0 0 0
Other respiratory disorders / diseases
Reproductive Health and Childbirth 0 0 0 0
Complications of newborn
Injuries and Accidents 0 0 0 0
Other injuries and accidents
Cardiovascular 0 0 0 0
Diseases of the vasculature and circulation including the lymphatic system
Cardiovascular 0 0 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Comparator / control treatment
Control group

Outcomes

Eligibility
Key inclusion criteria
- Patients receiving ECMO in Australia and New Zealand
Minimum age
16 Years
Maximum age
No limit
Gender
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria

Study design
Purpose
Duration
Selection
Timing
Retrospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 0 0
Alfred Hospital - Melbourne
Recruitment postcode(s) [1] 0 0
3004 - Melbourne

Funding & Sponsors
Primary sponsor type
Other
Name
Bayside Health
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Extracorporeal membrane oxygenation (ECMO) is a means of artificially performing the function
of the human lung and/or heart outside the body. Its use is escalating in a wide range of
clinical settings in the adult population without evidence or guidelines to support this
practice.

This study involves a nationwide questionnaire which has two components. The initial pilot
survey will attempt to identify all institutions currently practicing ECMO or those intending
to do so in the future, and are willing to participate in prospective data collection. The
second phase will involve a monthly survey of these centres regarding the extent of ECMO use,
practice details implemented, and outcome data.

It is hoped that the collection of this information will later assist in the development of
guidelines for this expensive and presently unsubstantiated practice, together with the
construction of appropriate training programs for staff.
Trial website
https://clinicaltrials.gov/show/NCT00157144
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Vincent A Pellegrino, MBBS
Address 0 0
National Health and Medical Research Council, Australia
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Summary results
Other publications